HIV and AIDS Trial, Recruiting NCT06745947 Sponsor: The University of Texas Health Science Center at San Antonio Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT06745947
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 34 years old
  • People who have tested negative for HIV using a rapid HIV antibody test
  • People who identify as gay or bisexual
  • People who have used methamphetamine in the past 3 months
  • People who have been prescribed HIV PrEP medication and are currently taking it
  • People who report not having taken their HIV PrEP medication as prescribed in the past 3 months
  • People whose urine test results indicate they have not been taking PrEP as prescribed
  • People who report having anal sex without a condom, or having had a sexually transmitted infection (STI), in the past 3 months
  • People who are able to attend all required study visits
  • People who are fluent in English

Who may not be able to join:

  • People who are currently receiving treatment for a substance use disorder
  • People who are HIV positive
  • People with a medical or mental health condition that the principal investigator (the doctor leading the trial) believes would interfere with taking part in the study (confirm with trial site)
  • People who are not able to give informed consent
  • People who are not able to attend the required study visits
  • People who have plans that would prevent them from completing the study, such as upcoming surgery, major medical treatments like chemotherapy, incarceration, or plans to travel or move away from San Antonio, Texas

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Emeka Okafor, PhD, MPH, The University of Texas Health Science Center at San Antonio

Phone: 210-450-7377

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The University of Texas Health Science Center at San Antonio
Registry
ClinicalTrials.gov
Start date
3 March 2025
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Dried Blood Spot Analysis for PrEP adherence; Urine Collection for Drug Screening; Urine Collection for Sexually Transmitted Infections (STIs); Rectal Swab for STI testing; Pre-exposure Prophylaxis (PrEP) Related Intentions; PrEP Attitudes; PrEP Stigma; PrEP Self-efficacy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov